
Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
Oncology Today with Dr Neil Love
00:00
T-DXd tolerability and ILD risk
Terence shares his clinical experience: manageable GI toxicity and ILD risk with vigilance, especially in frail patients.
Play episode from 14:36
Transcript


